Cargando…

Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis

BACKGROUND: The benefits and safety of medications for attention-deficit hyperactivity disorder (ADHD) remain controversial, and guidelines are inconsistent on which medications are preferred across different age groups. We aimed to estimate the comparative efficacy and tolerability of oral medicati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cortese, Samuele, Adamo, Nicoletta, Del Giovane, Cinzia, Mohr-Jensen, Christina, Hayes, Adrian J, Carucci, Sara, Atkinson, Lauren Z, Tessari, Luca, Banaschewski, Tobias, Coghill, David, Hollis, Chris, Simonoff, Emily, Zuddas, Alessandro, Barbui, Corrado, Purgato, Marianna, Steinhausen, Hans-Christoph, Shokraneh, Farhad, Xia, Jun, Cipriani, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109107/ https://www.ncbi.nlm.nih.gov/pubmed/30097390 http://dx.doi.org/10.1016/S2215-0366(18)30269-4

Ejemplares similares

Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis
por: Cortese, Samuele, et al.
Publicado: (2017)

The quality of life of children with attention deficit/hyperactivity disorder: a systematic review
por: Danckaerts, Marina, et al.
Publicado: (2009)

Starting ADHD medications during the COVID-19 pandemic: recommendations from the European ADHD Guidelines Group
por: Cortese, Samuele, et al.
Publicado: (2020)

Attention-Deficit/Hyperactivity Disorder (ADHD) and Obesity: Update 2016
por: Cortese, Samuele, et al.
Publicado: (2017)

Comparative cardiovascular side effects of medications for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis
por: Lannes, Alice, et al.
Publicado: (2022)

Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate
por: Coghill, David R., et al.
Publicado: (2018)

Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
por: Coghill, David, et al.
Publicado: (2013)

Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder
por: Coghill, David R., et al.
Publicado: (2017)

Erratum to: Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
por: Coghill, David, et al.
Publicado: (2015)

The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)
por: Coghill, David, et al.
Publicado: (2021)

Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial
por: Coghill, David R, et al.
Publicado: (2014)

ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group
por: Cortese, Samuele, et al.
Publicado: (2020)

Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study
por: Inglis, S K, et al.
Publicado: (2016)

Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
por: Banaschewski, Tobias, et al.
Publicado: (2018)

Health-Related Quality of Life and Functional Outcomes from a Randomized, Controlled Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention Deficit Hyperactivity Disorder
por: Banaschewski, Tobias, et al.
Publicado: (2013)

Health-Related Quality of Life and Functional Outcomes from a Randomized-Withdrawal Study of Long-Term Lisdexamfetamine Dimesylate Treatment in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
por: Banaschewski, Tobias, et al.
Publicado: (2014)

Temperament Dimensions and Awakening Cortisol Levels in Attention-Deficit/Hyperactivity Disorder
por: Carta, Alessandra, et al.
Publicado: (2022)

Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial
por: Coghill, David R., et al.
Publicado: (2013)

Molecular genetics of attention-deficit/hyperactivity disorder: an overview
por: Banaschewski, Tobias, et al.
Publicado: (2010)

Pharmacological and non-pharmacological interventions for adults with ADHD: protocol for a systematic review and network meta-analysis
por: Cortese, Samuele, et al.
Publicado: (2022)

Introducing RAPTOR: RevMan Parsing Tool for Reviewers
por: Schmidt, Lena, et al.
Publicado: (2019)

A Post Hoc Comparison of the Effects of Lisdexamfetamine Dimesylate and Osmotic-Release Oral System Methylphenidate on Symptoms of Attention-Deficit Hyperactivity Disorder in Children and Adolescents
por: Soutullo, César, et al.
Publicado: (2013)

European guidelines on managing adverse effects of medication for ADHD
por: Graham, J., et al.
Publicado: (2010)

Forty-five years of schizophrenia trials in Italy: a survey
por: Purgato, Marianna, et al.
Publicado: (2012)

Schizophrenia trials conducted in African countries: a drop of evidence in the ocean of morbidity?
por: Purgato, Marianna, et al.
Publicado: (2012)

Which psychotherapy is effective in panic disorder? And which delivery formats are supported by the evidence? Study protocol for two systematic reviews and network meta-analyses
por: Papola, Davide, et al.
Publicado: (2020)

Using the needs of WHO to prioritise Cochrane reviews: The case of antipsychotic drugs
por: Purgato, Marianna, et al.
Publicado: (2011)

Erratum to: Eunethydis: a statement of the ethical principles governing the relationship between the European group for ADHD guidelines, and its members, with commercial for-profit organisations
por: Sergeant, Joseph A., et al.
Publicado: (2010)

Eunethydis: a statement of the ethical principles governing the relationship between the European group for ADHD guidelines, and its members, with commercial for-profit organisations
por: Sergeant, Joseph A., et al.
Publicado: (2010)

Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD)
por: Banaschewski, Tobias, et al.
Publicado: (2018)

A network meta-analysis of psychosocial interventions for refugees and asylum seekers with PTSD
por: Turrini, Giulia, et al.
Publicado: (2021)

Remote assessment of ADHD in children and adolescents: recommendations from the European ADHD Guidelines Group following the clinical experience during the COVID-19 pandemic
por: Santosh, P., et al.
Publicado: (2023)

CBT treatment delivery formats for panic disorder: a systematic review and network meta-analysis of randomised controlled trials
por: Papola, Davide, et al.
Publicado: (2023)

Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine
por: Hennissen, Leonie, et al.
Publicado: (2017)

Post hoc analyses of response rates to pharmacological treatments in children and adolescents with attention-deficit/hyperactivity disorder
por: Coghill, David R, et al.
Publicado: (2020)

Cognitive Training for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes From Randomized Controlled Trials
por: Cortese, Samuele, et al.
Publicado: (2015)

Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
por: Coghill, David R., et al.
Publicado: (2017)

Regional analysis of UK primary care prescribing and adult service referrals for young people with attention-deficit hyperactivity disorder: from little to very little
por: Cortese, Samuele
Publicado: (2020)

Attention-Deficit/Hyperactivity Disorder in Looked-After Children: a Systematic Review of the Literature
por: Willis, Renece, et al.
Publicado: (2017)

Common mental disorders in asylum seekers and refugees: umbrella review of prevalence and intervention studies
por: Turrini, Giulia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e9nq835mv1rl53h8fesn41htqs